GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Golden Throat Holdings Group Co Ltd (HKSE:06896) » Definitions » Capital Expenditure

Golden Throat Holdings Group Co (HKSE:06896) Capital Expenditure : HK$-71.91 Mil (TTM As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Golden Throat Holdings Group Co Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Golden Throat Holdings Group Co's cash flow for capital expenditures for the six months ended in Dec. 2024 was HK$-56 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-71.91 Mil.

Golden Throat Holdings Group Co Capital Expenditure Historical Data

The historical data trend for Golden Throat Holdings Group Co's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Golden Throat Holdings Group Co Capital Expenditure Chart

Golden Throat Holdings Group Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -99.52 -69.26 -17.70 -19.18 -71.77

Golden Throat Holdings Group Co Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.48 -8.61 -10.58 -15.97 -55.94

Golden Throat Holdings Group Co Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-71.91 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Golden Throat Holdings Group Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Golden Throat Holdings Group Co Ltd (HKSE:06896) » Definitions » Capital Expenditure
Comparable Companies
HKSE:01061 HKSE:02633 HKSE:02561 HKSE:02552 HKSE:02161 HKSE:02877 HKSE:02348 HKSE:08049 HKSE:01349 HKSE:00950 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
No. 28, Fengxiang Road, Guangxi Zhuang Autonomous Region, Liuzhou, CHN
Website
http://www.goldenthroat.com
Golden Throat Holdings Group Co Ltd is an investment holding company. Through its subsidiaries, the company is engaged in the manufacture and sale of pharmaceuticals, healthcare food and other products. It manufactures and sells lozenges and other pharmaceutical and food products. The key products of the group that derives revenue for the group are Golden Throat Lozenges (OTC), Golden Throat Lozenge Series products and other products. The group derives majority of its revenue from Mainland China.

Golden Throat Holdings Group Co Headlines

No Headlines